LNTH:NASDAQ
Lantheus Holdings Inc
$99.94
arrow_downward
-0.25%(-0.26) 1D
Oct 6, 1:49:36 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for LNTH...
Open
$100.28
High
$100.34
Low
$99.89
Mkt. cap
6.51B
Avg. vol.
1.02M
Volume
352.08K
P/E ratio
24.18
52-wk high
$111.86
52-wk low
$49.67
EPS
$4.13
Beta
-0.06
Shares outstanding
65.30M
No. of employees
1K
Open
$100.28
High
$100.34
Low
$99.89
Mkt. cap
6.51B
Avg. vol.
1.02M
Volume
352.08K
P/E ratio
24.18
52-wk high
$111.86
52-wk low
$49.67
EPS
$4.13
Beta
-0.06
Shares outstanding
65.30M
No. of employees
1K
News stories
From web sources and news partners
The Washington Post
·
1 hour ago
Stocks hit new record high even as consumers feel dreary
MarketForces Africa
·
39 minutes ago
XRP Establishes Price Floor Ahead Of Evernorth Nasdaq Listing
Simply Wall Street
·
13 minutes ago
Sovereign AI Deal Might Change The Case For Investing In Palantir (PLTR)
Yahoo Finance
·
51 minutes ago
The Nasdaq Just Hit a Record High -- Are You Overexposed to AI Without Realizing It?
Profile
Lantheus, headquartered in Billerica, Massachusetts, is a company in the radiopharmaceuticals business. It has strategic partnerships with Bayer, Novartis, Regeneron as well as GE Healthcare and Siemens Healthineers.
Lantheus Holding, which became a NASDAQ company in 2015, is the parent company of Lantheus Medical Imaging, Inc., Progenics Pharmaceuticals, Inc. and EXINI Diagnostics AB. Lantheus has offices in Massachusetts, New Jersey, Canada and Sweden.
Brian Markison has served as the company's CEO since March 1, 2024, following the retirement of Mary Anne Heino, who had led Lantheus for the preceding decade. Wikipedia
About Lantheus Holdings Inc
CEO-
Employees1.19K
Founded1956
HeadquartersNorth Billerica, Massachusetts, United States
SectorMedical device
Websitelantheus.com